Home / Choriogonadotropin Alfa / Canada
CA ATC G03GA08 · updated 2 Nov 2026
Choriogonadotropin Alfa shortage in Canada
Is there a Choriogonadotropin Alfa shortage in Canada?
Yes. As of 2 Nov 2026, 1 Choriogonadotropin Alfa product is reported short in Canada, the first since 2 Sep 2024. The company estimate for the return is 30 Dec 2026. Main reason: increased demand.
Also short in Ireland, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | OVIDREL (1 pen) | EMD SERONO, A DIVISION OF EMD INC., CANADA | 2 Sep 2024 | 30 Dec 2026 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.